In this presentation and quiz bowl, I explain what Tay-Sachs Disease is, how it is determined, how lethal it is, and possible treatment options. I also provide an overview of basic genetics, molecular biology, and a few experimental techniques! Enjoy! At the end of each of section, there are quiz questions. So break into teams and enjoy the presentation!
Gaucher disease is an inherited disorder that
affects many of the body's organs and tissues. The signs and symptoms of this
condition vary widely among affected individuals. Researchers have described
several types of Gaucher disease based on their characteristic features.
Type 1 Gaucher disease is the most common
form of this condition. Type 1 is also called non-neuronopathic Gaucher disease
because the brain and spinal cord (the central nervous system) are usually not
affected. The features of this condition range from mild to severe and may
appear anytime from childhood to adulthood. Major signs and symptoms include
enlargement of the liver and spleen (hepatosplenomegaly), a low number of red
blood cells (anemia), easy bruising caused by a decrease in blood platelets
(thrombocytopenia), lung disease, and bone abnormalities such as bone pain,
fractures, and arthritis.
Types 2 and 3 Gaucher disease are known as
neuronopathic forms of the disorder because they are characterized by problems
that affect the central nervous system. In addition to the signs and symptoms
described above, these conditions can cause abnormal eye movements, seizures,
and brain damage. Type 2 Gaucher disease usually causes life-threatening
medical problems beginning in infancy. Type 3 Gaucher disease also affects the
nervous system, but tends to progress more slowly than type 2.
The most severe type of Gaucher disease is
called the perinatal lethal form. This condition causes severe or
life-threatening complications starting before birth or in infancy. Features of
the perinatal lethal form can include extensive swelling caused by fluid
accumulation before birth (hydrops fetalis); dry, scaly skin (ichthyosis) or
other skin abnormalities; hepatosplenomegaly; distinctive facial features; and
serious neurological problems. As its name indicates, most infants with the
perinatal lethal form of Gaucher disease survive for only a few days after
birth.
Another form of Gaucher disease is known as
the cardiovascular type because it primarily affects the heart, causing the
heart valves to harden (calcify). People with the cardiovascular form of
Gaucher disease may also have eye abnormalities, bone disease, and mild
enlargement of the spleen (splenomegaly).
Gaucher disease is an inherited disorder that
affects many of the body's organs and tissues. The signs and symptoms of this
condition vary widely among affected individuals. Researchers have described
several types of Gaucher disease based on their characteristic features.
Type 1 Gaucher disease is the most common
form of this condition. Type 1 is also called non-neuronopathic Gaucher disease
because the brain and spinal cord (the central nervous system) are usually not
affected. The features of this condition range from mild to severe and may
appear anytime from childhood to adulthood. Major signs and symptoms include
enlargement of the liver and spleen (hepatosplenomegaly), a low number of red
blood cells (anemia), easy bruising caused by a decrease in blood platelets
(thrombocytopenia), lung disease, and bone abnormalities such as bone pain,
fractures, and arthritis.
Types 2 and 3 Gaucher disease are known as
neuronopathic forms of the disorder because they are characterized by problems
that affect the central nervous system. In addition to the signs and symptoms
described above, these conditions can cause abnormal eye movements, seizures,
and brain damage. Type 2 Gaucher disease usually causes life-threatening
medical problems beginning in infancy. Type 3 Gaucher disease also affects the
nervous system, but tends to progress more slowly than type 2.
The most severe type of Gaucher disease is
called the perinatal lethal form. This condition causes severe or
life-threatening complications starting before birth or in infancy. Features of
the perinatal lethal form can include extensive swelling caused by fluid
accumulation before birth (hydrops fetalis); dry, scaly skin (ichthyosis) or
other skin abnormalities; hepatosplenomegaly; distinctive facial features; and
serious neurological problems. As its name indicates, most infants with the
perinatal lethal form of Gaucher disease survive for only a few days after
birth.
Another form of Gaucher disease is known as
the cardiovascular type because it primarily affects the heart, causing the
heart valves to harden (calcify). People with the cardiovascular form of
Gaucher disease may also have eye abnormalities, bone disease, and mild
enlargement of the spleen (splenomegaly).
Takayasu arteritis (TA) is a rare nonspecific inflammatory disease of unknown cause, predominantly affecting
the aorta and its main branches, coronary arteries, and pulmonary arteries of young females. It induces a variety
of nonspecific inflammatory symptoms and ischemic symptoms due to stenotic lesions. Further progression
of TA causes destruction of the arterial wall media, leading to aortic regurgitation and aneurysms or
rupture of the involved arteries. Although serological tests specific for TA are not available, new better biomarkers
are emerging such as pentraxin3 and matrix metalloproteinases. Recent advances in imaging modalities
including magnetic resonance angiography, computed tomography (CT), sonography, and fluorodeoxy
glucose positron emission tomography/CT (FDG-PET/CT) allow earlier and accurate diagnosis of TA. Duration
between onset of the disease and diagnosis has become much shorter during the last decade. Medical treatment
for TA is also changing. In addition to the traditional glucocorticoids and immunosuppressants, many
new biological agents are being applied to patients with TA refractory to conventional treatment with favorable
results. As for treatment for vascular complications, efficacy of endovascular treatment is still a matter of
controversy because of the high rate of restenosis at an early stage after the procedure. Based on these advances,
the prognosis and quality of life of TA patients have improved to a great deal. However, there are
many issues that remain to be solved in the management of TA.
Identifying rare genetic variation in obsessive compulsive disorderTÀI LIỆU NGÀNH MAY
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
Integrative Medicine and Experimental Pharmacogenomic Therapy in a Child with...Sophia's Garden Foundation
A 34-month female with Niemann-Pick Disease, Type A (NPD-A) is presented. NPD-A is a rare autosomal recessive, hereditary lysosomal storage disease caused by reduced acid sphingomyelinase (ASM) activity. Reduced sphingomyelinase activity resulting in impaired sphingomyelin turnover leads to cellular lipid and lysosomal storage (foam cells), hepatosplenomegaly, delay and loss of developmental milestones, and degenerative neurologic deficits. Death occurs in infancy or early childhood, with the usual life span being 2-3 years. No effective treatment for NPD-A is known, although bone marrow transplantation and enzyme replacement therapy with ASM have been attempted. [Both have been tried for NPD-B, but I do not know if either of these techniques have been tried for NPD-A. This is true that no successful treatment has been demonstrated for humans with NPD-A, yet the Genzyme studies using adeno viruses were successful for mice.
See <http://www.genzyme.co.uk/corp/news/all_news/GENL%20PR-060503.asp>. Stem cell and gene therapy research is being investigated in animal models. This child is known to have an unusual stop-codon mutation. Aminoglycosides have been found in animal and small-scale human studies to cause read-through in translation effectively skipping the “stop-codon” and are in clinical trials in other genetic diseases with similar mutations. It was hypothesized that gentamicin would cause read-through in translation in this patient, and thereby increase production of acid sphingomyelinase. After presentation to the Ethics Committee of Lucile Salter Packard Children’s Hospital at Stanford University, the child was treated with an experimental protocol using intranasal gentamicin. This is the first case of NPD-A in which this has been tried.
This patient has also been treated with Traditional Chinese Medicine including acupuncture and botanicals, massage therapy, nutritional measures, homeopathy, energy healing and compassionate intention in an Integrative Medicine approach. Disease characteristics, clinical features and course will be described.
Tay-Sachs disease is caused by a mutation (abnormal change) in the g.pdfmukhtaransarcloth
Tay-Sachs disease is caused by a mutation (abnormal change) in the gene that codes for Hex-A,
and it is a recessive trait. This means that people will have the disease if they have two copies of
the defective gene, but they will not have the disease if they have at least one unaffected copy.
People with one normal copy and one defective copy are called carriers, because they can pass
the disease on to their children.
Seizures are sudden altacks of disease, often referring to some type of violent spasms.
Just about anyone can be a carrier of the gene for Tay-Sachs disease. In the general population,
about 1 in 250 people carries the gene.
People inherit Tay-Sachs disease when they inherit a defective gene from both parents, resulting
in two defective genes that make the body unable to produce Hex-A correctly. People who have
only one defective gene are called carriers. Carriers do not have the disease, because they have
inherited one healthy gene to code for Hex-A, but they may pass the defective gene on to their
children. If both parents are carriers, each child born to them has a 1 in 4 liklihood of having the
disease.
However, some populations of people include more carriers than others. For example, 1 in 27
people of eastern European Jewish (Ashkenazi) descent in the United States is a carrier. People
of French-Canadian ancestry from one part of Quebec and the Cajunpopulation in Louisiana also
have a higher than usual risk of carrying the Tay-Sachs gene.
Solution
Tay-Sachs disease is caused by a mutation (abnormal change) in the gene that codes for Hex-A,
and it is a recessive trait. This means that people will have the disease if they have two copies of
the defective gene, but they will not have the disease if they have at least one unaffected copy.
People with one normal copy and one defective copy are called carriers, because they can pass
the disease on to their children.
Seizures are sudden altacks of disease, often referring to some type of violent spasms.
Just about anyone can be a carrier of the gene for Tay-Sachs disease. In the general population,
about 1 in 250 people carries the gene.
People inherit Tay-Sachs disease when they inherit a defective gene from both parents, resulting
in two defective genes that make the body unable to produce Hex-A correctly. People who have
only one defective gene are called carriers. Carriers do not have the disease, because they have
inherited one healthy gene to code for Hex-A, but they may pass the defective gene on to their
children. If both parents are carriers, each child born to them has a 1 in 4 liklihood of having the
disease.
However, some populations of people include more carriers than others. For example, 1 in 27
people of eastern European Jewish (Ashkenazi) descent in the United States is a carrier. People
of French-Canadian ancestry from one part of Quebec and the Cajunpopulation in Louisiana also
have a higher than usual risk of carrying the Tay-Sachs gene..
Breaking down Biology into simpler bits is the most effective way to learn hence this presentation aims to simplify the concept of 'Linked Inheritance' which makes understanding Inheritance better.
Answer part a)According to the gene map of the wild type and the m.pdfappsmobileshoppe
Answer part a)
According to the gene map of the wild type and the mutant gene, it can be seen that the mutant
lacks a site for restriction digestion. This shows that in wild type, the restriction enzyme can
digest the DNA at any three sites and thus atleast two bands will appear after amplification. On
the contrary, the deletion of middle sequence of restriction site will lead to formation of a single
band in mutant gene. The smaller band will represnt the mutant and the larger band will
represent the normal/wild type allele. Thus, according to this information, it can be deciphered
that the mother is a heterozygous in nature and carries a mutant allele for Tay-Sachs disease
while the father does not. Thus, the lower band will be a representative of mutant or \"t\" and the
upper band will be a representative of normal \"T\" allele.
Answer part b)
Since the mother is a carrier, there are 50% chances that the mother will transmit the mutant
allele to her offspring. Thus, the couple can bear a normal heterozygous carrier female offspring
or an affected male offspring. According to the information in the image, the genotype bands of
father and offspring match which clearly suggest that the offspring is an unaffected heterozygous
carrier female.
Answer part c)
There are always 50% changes for a male to be affected by the disease. Rest 50% males will be
normal both geotypically and phenotypically. Also, all the females will be phenotypically normal
but 50% of them would be heterozygous carriers.
Genotypes: XtX : XtY : XX : XY :: 1:1:1:1
Phenotypes: Affected : normal : carriers :: 1: 2: 1XYXtXtXXtYXXXXY
Solution
Answer part a)
According to the gene map of the wild type and the mutant gene, it can be seen that the mutant
lacks a site for restriction digestion. This shows that in wild type, the restriction enzyme can
digest the DNA at any three sites and thus atleast two bands will appear after amplification. On
the contrary, the deletion of middle sequence of restriction site will lead to formation of a single
band in mutant gene. The smaller band will represnt the mutant and the larger band will
represent the normal/wild type allele. Thus, according to this information, it can be deciphered
that the mother is a heterozygous in nature and carries a mutant allele for Tay-Sachs disease
while the father does not. Thus, the lower band will be a representative of mutant or \"t\" and the
upper band will be a representative of normal \"T\" allele.
Answer part b)
Since the mother is a carrier, there are 50% chances that the mother will transmit the mutant
allele to her offspring. Thus, the couple can bear a normal heterozygous carrier female offspring
or an affected male offspring. According to the information in the image, the genotype bands of
father and offspring match which clearly suggest that the offspring is an unaffected heterozygous
carrier female.
Answer part c)
There are always 50% changes for a male to be affected by the disease. Rest 50% males w.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. What am I doing?
My goals are to explain:
What is Tay-Sachs Disease?
3. What am I doing?
My goals are to explain:
What is Tay-Sachs Disease
How is it determined?
4. What I am doing?
My goals are to explain:
What is Tay-Sachs Disease
How is it determined?
Who can have it and how lethal is it?
5. What am I doing?
My goals are to explain:
What is Tay-Sachs Disease
How is it determined?
Who can have it and how lethal is it?
What are the treatment options?
6. What am I doing?
My goals are to explain:
What is Tay-Sachs Disease
How is it determined?
Who can have it and how lethal is it?
What are the treatment options?
How can it be prevented?
7. Patient Case Study and Ethics
Afterwards, I will present a mock patient case study and
an ethical dilemma.
9. Interactive Quiz Bowl
You will work in teams and you will have two minutes to
answer each question.
10. Note of Warning
Before Beginning:
You should have a competent understanding of DNA,
RNA, and the Central Dogma
11. Note of Warning
Before Beginning:
You should have a competent understanding of DNA,
RNA, and the Central Dogma
Genes and the types of mutations
12. Notes of Warning
Before Beginning:
You should have a competent understanding of DNA,
RNA, and the Central Dogma
Genes and the types of mutations
The endomembrane system
13. Note of warning
Before Beginning:
You should have a competent understanding of DNA,
RNA, and the Central Dogma
Genes and the types of mutations
The endomembrane system
The Plasma Membrane
14. Notes of Warning
Before Beginning:
You should have a competent understanding of DNA,
RNA, and the Central Dogma
Genes and the types of mutations
The endomembrane system
Plasma Membrane
Here are some helpful links:
http://www.ncbi.nlm.nih.gov/Class/MLACourse/Modules/
MolBioReview/slide_list.html
http://www.youtube.com/watch?v=UAaTEjYmxso
http://en.wikipedia.org/wiki/Cell_membrane
16. What is TaySachs Disease
It is a lysosomal storage
disorder due to genetic
mutations in the HEX A gene.
17. What is TaySachs Disease?
• One common mutation is a 4
base insertion in the HEX A
gene.
18. What is TaySachs?
As we know, this could change
how the RNA is transcribed and
the resultant protein.
19. What is TaySachs Disease?
And in fact, it does change the
protein. The HEX A gene is
responsible for the production
of an enzyme(protein) called βhexsaminidase A that is
responsible for breaking down
fatty substances called GM2
gangliosides that can
accumulate in our brains and
spinal cords.
20. What is TaySachs Disease?
These enzymes(proteins) are
made on ribosomes attached to
the rough ER and sent to
lysosomes that act as recycling
centers to break down toxic
substances such as fatty
substances called GM2Gangliosidies that accumulate
in our nervous system.
Often lack of function of these
enzymes results in death.
21. What is TaySachs Disease?
GM2 gangliosides contain a long
hydrophobic tail that inserts
itself into the plasma
membrane of ganglion cells in
neurons surrounding the retina
of our eyes.
Pictures: (top) Hexsaminidase
with both alpha and beta
subunits. Only the alpha
subunit is involved in Tay-Sachs
Disease. (bottom) is a depiction
of a GM2-ganglioside.
22. What is TaySachs Disease?
They also contain acidic groups
called head groups that stick
above the plasma membrane
and can be involved in cell-cell
recognition as a result.
While the exact function of GM2
Gangliosides is unknown, it has
been suspected that they serve
as an intermediate in the
synthesis of more complex
gangliosides needed for normal
brain development.
23. What is TaySachs Disease?
This would explain why the
enzyme HEX A cleaves part of
the ganglioside and the
absence of this enzyme results
in improper brain development
often culminating in death.
24. What is TaySachs Disease?
On another note, this disease is
known as an autosomal
recessive disorder
25. What is TaySachs Disease?
An autosomal recessive
disorder means that the
mutation in the HEXA gene
exists in two alleles. Alleles are
alternative form of a gene.
Humans contain two sets of
genes, one from their
mother, and one from their
father. The offspring must have
two alleles, one from the
mother and the father, in order
for the disease to be expressed.
26. What is TaySachs Disease?
The actual enzyme activity
required by β-hexosaminidase
is very small in order to
sufficiently break down GM2gangliosides. Thus, some
individuals may only have one
mutant copy of the HEXA gene.
These individuals will have
abnormally low enzyme activity
levels, but still enough to break
down fatty substances in your
nervous system.
They are called heterozygous
carriers.
27. What is TaySachs Disease?
If two of these heterozygous
carriers with abnormal enzyme
levels mate, they have a 25%
chance of having a child
affected with Tay-Sachs
Disease. This would mean that
each parent has 1 mutant copy
out of two (1/2) and the child
has both copies; thus the
probability is ½ x ½ = ¼ or
25% that the child will be
affected.
This is the basis for a recessive
disorder.
We see in this family tree, the
offspring ratio is 3:1 and 25%
chance of being affected.
28. What is TaySachs Disease
We can also illustrate this
concept through a punnett
square. Lets represent A as the
normal HEX A allele(alternative
form of gene) and a as the
mutant allele that produces
abnormal HEX A enzyme levels.
29. What is TaySachs Disease?
As you can see, when you cross
two heterozygotes, you get a
25% chance of being affected.
30. What is TaySachs Disease?
Now, to further complicate
matters, it is important to
realize that more than 120
mutations have been found in
the HEX A gene.
These mutations vary in the
amount of β-hexosaminidase
they produce and thus lead to
less severe forms of the
disease.
31. What is TaySachs Disease
This leads to two subtypes of
Tay- Sachs Disease:
1) Early-onset Infantile: the
child possesses two mutant
copies of the HEX A and
produces no functional
enzyme. This the most
severe.
32. What is TaySachs Disease?
This leads to two subtypes TaySachs Disease:
1) Early-onset Infantile: the
child possesses two mutant
copies of the HEX A and
produces none of the
functional enzyme. This the
most severe.
2) Late – onset adult: disease
caused at times by
compound heterozygosity
that I will explain later.
Patient has abnormal
enzyme levels resulting in
late-onset disease.
The images present a young
child with Tay-Sachs and an
adult with Tay-Sachs
34. Quiz Question 1
The following Base Sequence is the normal gene
sequence: AGTCGTTAACCAG
Although the above sequence is not the HEX A gene,
what mutational sequence below could be analogous to
Tay-Sachs?
A. AGTCGTTCAACCAG
B. AGTCGTTCCAACCAG
C. AGTCGTTCCGGAACCAG
D. : AGTCGTTAACCAG
36. Quiz Question 1
The following Base Sequence is the normal gene sequence:
AGTCGTTAACCAG
Although the above sequence is not the HEX A gene, what
mutational sequence below could be analogous to TaySachs?
A. AGTCGTTCAACCAG
B. AGTCGTTCCAACCAG
C. AGTCGTTCCGGAACCAG
D. : AGTCGTTAACCAG
THE ANSWER is C. A common mutation found in the HEX A
gene can result from a 4 base pair insertion! Give yourself 2
points if you got it right. But note, that other mutations are
also possible.
38. Quiz Question 2
If a male contains one mutant allele for the HEX A gene
(Aa) and the female contains two normal alleles(AA),
then what is the chance that they will have an offspring
with Tay-Sachs? Hint: Draw a Punnett Square.
A. 75%
B. 60%
C. 25%
D. None of the above
40. Quiz Question 2
If a male contains one mutant allele for the HEX A gene
(Aa) and the female contains two normal
alleles(AA), then what is the chance that they will have
an offspring with Tay-Sachs? Hint: Draw a Punnett
Square.
A. 75%
B. 60%
C. 25%
D. None of the above
THE ANSWER IS D. Tay-Sachs is a recessive disorder
meaning that the offspring has to have two mutant alleles.
Only one mutant allele is available. The answer should be
0%.
41. Question 2: mathematics
explained
Here is an example of how this problem could be solved.
1) Make a punnett square.
A
A
AA
AA
a
A
Aa
Aa
2)Perform data analysis. For example, we can say that 2/4 of the
offspring or 50% will be heterozygous carriers. The remaining 50%
will be homozygous dominant; thus, since there are no homozygous
recessive offspring, we can say there is a 0% probability of the
offspring having a recessive disease such as Tay- Sachs.
43. Question 3
The following blood test was conducted on a patient. The
lab found his β-hexosaminidase levels to be operating at
15%. This means that 15% of the enzymes were
functioning normally. Can we conclude the patient has
Tay-Sachs?
A. Yes
B. No
C. Not sure yet.
45. Question 3
The following blood test was conducted on a patient. The
lab found his β-hexosaminidase levels to be operating at
15%. This means that 15% of the enzymes were
functioning normally. Can we conclude the patient has
Tay-Sachs?
A. Yes
B. No
C. Not sure yet.
THE ANSWER IS B. Remember that the enzyme only
requires small amounts to function normally. This also
ties in to our discussion about different mutations
producing different activity levels. We will discuss more
about “critical thresholds” in the next section.
46. Tally your scores
Tally your points. The maximum score is 6 and the
minimum score is 0.
47. How is TaySachs Disease
determined?
Now that we know what this
disease is. We need to know
how is it determined in the lab.
48. How is TaySachs
Determined?
Tay-Sachs is primarily
determined by a blood test. An
individual with a family history
of Tay-Sachs can consult their
physician and receive a simple
blood test that measures βhexosaminidase levels.
49. How is TaySachs Disease
Determined?
Remember Quiz Question 3?
Well, it turns out that
individuals affected with TaySachs Disease have between
0% activity to 10% activity.
Infantile Tay-Sachs patients
have 0%. Adult patients have
an activity level between 510% to produce symptoms.
Any amount greater than 10%
will result in no symptoms.
51. How is TaySachs Disease
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
1) Cherry red- spot: results
from the accumulation of GM2gangliosides that can block
blood supply, disrupt a patient’s
vision, and inhibit normal brain
development. Prime indicator of
Tay-Sachs.
52. How is TaySachs Disease
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
1) Cherry red- spot: results
from the accumulation of GM2gangliosides that can block
blood supply and disrupt a
patient’s vision. Prime indicator
of Tay-Sachs.
2) In children, symptoms arise
within 3 to 6 months. Children
lose motor skills such as the
ability to crawl.
53. How is TaySachs Disease
Determined?
Individuals with blood levels at
or below this “critical threshold
possess visible symptoms such
as:
1) Cherry red- spot: results
from the accumulation of GM2gangliosides lipids that can
block blood supply and disrupt
a patient’s vision. Prime
indicator of Tay-Sachs.
2) In children, symptoms arise
within 3 to six months.
Children lose motor skills such
as the ability to crawl.
3) Eventually, affected
individuals can experience
seizures, paralysis, and loss of
intellectual abilities due to their
nerve cells dying.
54. How is TaySachs Disease
Determined?
Individuals with blood levels at or
below this “critical threshold
possess visible symptoms such as:
1) Cherry red- spot: results from
the accumulation of GM2gangliosides lipids that can block
blood supply and disrupt a
patient’s vision. Prime indicator of
Tay-Sachs.
2) In children, symptoms arise
within 3 to six months. Children
lose motor skills such as the ability
to crawl.
3) Eventually, affected individuals
can experience seizures, paralysis,
and loss of intellectual abilities due
to their nerve cells dying.
4) Microscopic Analysis can also
find the retinal neurons to be
bloated from excess ganglioside
storage.
Pictures: The top image represents bloated
retinal neurons from excess ganglioside storage
due to hexosaminidase deficiency.
57. How is TaySachs Disease
Determined?
The Answer can be solved
through three related
methodologies:
1) PCR
2) Gel Electrophoresis
58. How is TaySachs Disease
Determined?
The Answer can be solved
through three related
methodologies:
1) PCR
2) Gel Electrophoresis
3) DNA Sequencing
59. How is TaySachs Disease
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
60. How is TaySachs Disease
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
1) RNA isolation: You have to
isolate the RNA from your
sample and covert it back to
DNA using enzymes known as
reverse transcriptases. This
allows you to only amplify the
region that is expressed.
61. How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
1) RNA isolation: You have to
isolate the RNA from your
sample and covert it back to
DNA using enzymes known
as reverse transcriptases.
This allows you to only
amplify the region that is
expressed.
2) You then apply heat to your
DNA to pull the strands
apart.
62. How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
3) Anneal primers: attach
thermostable DNA sequences to
your DNA to begin the process
of amplification
63. How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
3) Anneal primers: attach
thermostable base DNA
sequence to your DNA to begin
the process of amplification
4) Add a thermostable
polymerase to attach to your
primers and begin replication.
64. How is TaySachs
Determined?
PCR stands for polymerase
chain reaction. This is done to
amplify a specific segment of a
chromosome such as the HEX
A gene or even a specific
segment of the Hex A gene.
The process can occur in 4 easy
steps:
3) Anneal primers: attach
thermostable base DNA
sequence to your DNA to begin
the process of amplification
4) Add a thermostable
polymerase to attach to your
primers and begin replication
5) Repeat to desired
amplification.
Picture: Diagram explaining
PCR.
65. How is TaySachs
Determined?
Now that you amplified DNA,
you can place it on a gel and
run an electric field through
your DNA segment. The
amplified DNA will show up on
the gel and move along the gel
against the negative electrode
since DNA contains negatively
charged phosphate groups.
66. How is TaySachs
Determined?
Mutant Hex A can be the result
of a 4 base pair insertion; thus,
it would have more phosphate
groups and move less along the
gel than a normal HEX A DNA
due to larger molecules getting
stuck in the gel. Think of the
gel as a sieve.
The following picture is an
example of data from a gel
electrophoresis experiment.
Smaller DNA fragments move
farther than larger DNA
fragments.
67. How is TaySachs
Determined?
Since Tay-Sachs is caused by
mutations, you can sequence
the HEX A gene of a normal
individual and an affected
individual and see the DNA
change. This is done in two
ways: Sanger Sequencing and
Cycle Sequencing via primers.
Attached are two videos to
watch that explains it in more
detail:
1) http://www.dnalc.org/resour
ces/animations/sangerseq.ht
ml
2) http://www.dnalc.org/view/1
5923-Cycle-sequencing.html
Picture on right depicts Fred
Sanger who developed Sanger
Sequencing. He recently died at
the age of 95.
68. QUIZ TIME!!
Now that you understand how mutations in the HEX A
gene can be determined, you can answer these
questions! Ready your troops!
69. Quiz Question 4:
A mother reports to her physician that her 4 month year
old just sits in one place for hours with no movement.
She has to be the one to move him at all times. She
suspects he may be paralyzed. What should the doctor
suggest first in his/her diagnosis?
A. Look for observational clues such as a cherry red spot
B. Perform a Microscopy Analysis to search for distended
neurons
C. Order a blood test to look for decreased βhexosaminidase activity levels.
D. Nothing. The woman is just a paranoid new mother.
71. Question 4
A mother reports to her physician that her 4 month year old just sits
in one place for hours with no movement. She has to be the one to
move him at all times. She suspects he may be paralyzed. What
should the doctor suggest first in his diagnosis?
A. Look for observational clues such as a cherry red spot
B. Perform a Microscopy Analysis to search for distended neurons
C. Order a blood test to look for decreased β-hexosaminidase
activity levels.
D. Nothing. The woman is just a paranoid new mother.
THE ANSWER IS A. While B and C are also possible, A is a
prime indicator of Tay-Sachs and is the easiest and probably
most convenient way to confirm Tay-Sachs.
73. Question 5
What feature of DNA structure dictates our rationale that
HEX A mutants with base pair insertions will result in
shorter distances along a gel?
A. Phosphate groups.
B. Sugar groups
C. Base pairs.
D. acridine ligands
75. Question 5
What feature of DNA structure dictates our rationale that
HEX A mutants with base pair insertions will have
shorter distances along a gel?
A. Phosphate groups.
B. Sugar groups
C. Base pairs.
D. acridine ligands
THE ANSWER IS A. While The phosphates in the
DNA backbone contain a negatively charged
oxygen that cause the DNA to repel against the
negative charged electrode, larger DNA fragments
get stuck in the gel more than smaller fragments
and thus move less.
76. Tally your scores!
The most points awarded up to this point are 10 points(2
points per question).
The least points awarded are 0 points
77. How lethal is
this disease?
Now that we understand what
Tay-Sachs disease is and how it
can be determined, we still
need to understand one other
factor before we can do a
patient case study. This last
factor is lethality.
78. How lethal is
this disease?
The most common form of TaySachs disease is infantile TaySachs. Symptoms normally
appear around 3 to 6 months.
The maximum longevity is
sadly only about 4 years or
simply a brief extent into early
childhood.
79. How lethal is
this disease?
Adult onset disease is more
variable depending on the
mutation and actual amount of
β-hexosaminidase activity
present in the cell.
80. How lethal is
this disease?
Another factor for adult onset
Tay-Sachs disease is the issue
of compound heterozygosity
that I mentioned previously.
81. How lethal is
this disease?
Compound Heterozygosity is
just weird. It occurs when an
individual has two recessive
allele mutations in the HEX A
gene at different locations in
the genome. This is indicative
of the fact that there are over
120 mutations found in the HEX
A gene. This can contribute to
adult onset Tay-Sachs as a
result.
82. How lethal is
this disease?
Another aspect of lethality is
the prevalence.
According to recent studies, 1
out of every 300 people in the
population is a heterozygous
carrier for Tay-Sachs disease.
However, for individuals who
belong to a certain ethnic group
known as the Ashkenazi Jews,
the prevalence increases from 1
in 300 people to 1 in 30 people
who will be a heterozygous
carrier.
Picture on the right depicts
women of Ashkenazi Jewish
heritage. They are genetically
European.
83. How lethal is
this disease?
The reason why the ratio is so
much greater for Ashkenazi
Jews is likely due to geographic
distributions. A paper published
in the American Journal of
Human Genetics found the
frequency of the HEX A
mutation to be greater in
geographically isolated regions
with the highest frequencies in
countries such as Russia,
Lithuania, and other central and
eastern European countries
where the Ashkenazi Jews
originated. As a result, the ratio
is likely just bad luck.
Figure. The geographic
locations of the Ashkenazi Jews
located in western and eastern
Europe including Russia.
Russia
85. Quiz Question 6
Which of the following pieces of evidence favors random
“bad luck” for the HEX A mutation in the Ashkenazi
Jewish population?
A. The ratio for a carrier is 1 out of 30 instead of 1 out of
300.
B. High mutation frequency in one location and no
frequnecy in other locations.
C. Heterozygous carriers are capable of producing subnormal enzyme activity levels to prevent symptoms from
appearing.
D. Some mutations in the HEX A are more deadly than
others.
87. Quiz Question 6
Which of the following pieces of evidence favor random
founder effects over heterozygous advantage for the HEX A
mutation in the Ashkenazi Jewish population?
A. The ratio for a carrier is 1 out of 30 instead of 1 out of
300.
B. High mutation frequency in one location and no
frequency in other locations.
C. Heterozygous carriers are capable of producing subnormal enzyme activity levels to prevent symptoms from
appearing.
D. Some mutations in the HEX A are more deadly than
others.
THE ANSWER IS B. Random founder effects occur
from genetic breeding/sampling in isolated
populations over long timespans.
88. Case Study of Alex
Now that you understand the basis of Tay-Sachs Disease
We can examine a mock case study.
Let’s begin
89. Meet Alex
Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
90. Meet Alex
Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
He is 3 months old.
91. Meet Alex
Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
He is 3 months old.
Alex is the first child of his parents.
92. Meet Alex
Alex, short for Alexander, is from Russia with two
Russian parents. They are part of the Ashkenazi Jewish
heritage.
Alex is 3 months old.
Alex is the first child of his parents
A physician observed an eye abnormality called a cherry
red spot through a simple eye examination.
94. Quiz Question 7
What should the doctor order based on these
evaluations?
A. blood test to measure α-hexosaminidase levels.
B. motor skills test.
C. Microscopy analysis of bloated nerve cells.
D. blood test to measure β- hexosaminidase levels.
96. Quiz Question 7
What should the doctor order based on these
evaluations?
A. blood test to measure α-hexosaminidase levels.
B. motor skills test.
C. Microscopy analysis of bloated nerve cells.
D. blood test to measure β- hexosaminidase levels.
THE BEST ANSWER IS D. Currently, the evidence is
strong for Tay-Sachs Disease, but we need to see if the
enzyme activity levels are below the “critical threshold”
levels.
100. Quiz Question 8
What should the doctor’s next recommendation be?
A. Order the lab to characterize the mutation through PCR
and gel electrophoresis
B. Nothing. The blood test is enough evidence.
C. Contact a genetic counselor
D. Re-run the blood test to confirm accuracy.
102. Quiz Question 8
What should the doctor’s next recommendation be?
A. Order the lab to characterize the mutation through
PCR and gel electrophoresis
B. Nothing. The blood test is enough evidence.
C. Contact a genetic counselor
D. Re-run the blood test to confirm accuracy.
THE ANSWER IS A. While one blood test is good
evidence, it does not tell us anything about the
genetics of the individual. Thus, it does not inform us
if a mutation is actually present.
104. Quiz Question 9
The results are in:
PCR and gel electrophoresis confirm shorter PCR
products indicating a base insertion.
105. Quiz Question 9
The results are in:
PCR and gel electrophoresis confirm shorter PCR
products indicating a base insertion.
DNA Sequencing confirms a 4 base addition for the HEX
A gene.
106. Quiz Question 8
The results are in:
PCR and gel electrophoresis confirm shorter PCR
products indicating a base insertion.
DNA Sequencing confirms a 4 base addition for the HEX
A gene.
This agrees with the blood test and observational clues
to confirm Tay-Sachs Disease.
108. Quiz Question 9
What are the possible treatment options given this new
diagnosis?
A. Gene therapy approaches that engineer viruses which
will turn the nerve cells into “micro factories” that
produce β-hexosaminidase.
B. Developing synthetic chaperones that guide the βhexosaminidase to fold into its native 3D structure.
C. Replace the β-hexsaminidase enzyme just like diabetics
undergo insulin replacement.
D. Use alternative enzymes that catabolize GM2gangliosides
110. Quiz Question 9
Patient X
=
The correct answer is none of
the above. All of the answer
choices exhibit examples of
positive research results, but
they are all still a long away
from actual clinical treatment.
So for now, Tay-Sachs
disease, in particular the
more common Infantile TaySachs Disease is a genetic
death sentence that will shut
down a child’s nervous
system before he/she
reaches kindergarden.
111. Quiz Question 9
As a result, when it comes to Tay-Sachs Disease,
especially infantile Tay-Sachs, no one is a winner and
that’s why no points are awarded for this question.
112. Quiz Question 9
As a result, when it comes to Tay-Sachs
Disease, especially infantile Tay-Sachs, no one is a
winner and that’s why no points are awarded for this
question.
Since Alex is afflicted with this disease, he will die and
his parents will be left childless.
113. Can this disease be prevented or
minimized?
1) Pre-natal genetic diagnosis: The parents can be
tested to see if they are carriers and if their offspring is
carrying both recessive alleles within 10 to 14 weeks.
The parents could then opt for abortion.
114. Can this disease be prevented or
minimized?
1) Pre-natal genetic diagnosis: The parents can be
tested to see if they are carrier and if their offspring is
carrying both recessive alleles within 10 to 14 weeks.
The parents could then opt for abortion.
2) Pre-implantation diagnosis: during in vitro
fertilization, you simply discard embryos that test
positive for Tay-Sachs disease.
115. Can this disease be prevented or
minimized?
1) Pre-natal genetic diagnosis: The parents can be
tested to see if they are carrier and if their offspring is
carrying both recessive alleles within 10 to 14 weeks.
The parents could then opt for abortion.
2) Pre-implantation diagnosis: during in vitro
fertilization, you simply discard embryos that test
positive for Tay-Sachs disease.
3) 3) Mate Selection: Some Orthodox Jewish groups
such as Dor Yeshorim perform a genetic screening
program that allows couple who test positive as carriers
can avoid conception.
116. Can this disease be prevented or
minimized?
These three strategies are pretty drastic and indicate
that we may still be a while away from actual treatment
options for this rare deadly disease. As a result, these
strategies have presented us with two ethical dilemmas.
117. Ethical Dilemma?
Does the current situation make an appropriate case for
abortion given that not all Tay-Sachs patients die in
infancy or childhood?
In this particular case, is knowledge good, bad, or
ambivalent?
118. Ethical Dilemma?
These are the important questions that we must address
and I leave them for you to decide the answer.